Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency

Pituitary

Volumn 11, Issue 1, 2008, Pages 55-61

  Mazziotti, Gherardo ^a   Bianchi, Antonio ^b   Cimino, Vincenzo ^b   Bonadonna, Stefania ^a   Martini, Paola ^a   Fusco, Alessandra ^b   De Marinis, Laura ^b   Giustina, Andrea ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Bone metabolism; Fracture; GH deficiency; GH replacement; Gonadal status; IGF 1

Indexed keywords

ANDROGEN; ESTROGEN; RECOMBINANT GROWTH HORMONE; VASOPRESSIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; CORRELATION ANALYSIS; DIABETES INSIPIDUS; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GONAD DEVELOPMENT; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPITUITARISM; MAJOR CLINICAL STUDY; MALE; MORPHOMETRICS; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPINE DISEASE;

ABSORPTIOMETRY, PHOTON; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE DENSITY; CROSS-SECTIONAL STUDIES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; HYPOGONADISM; HYPOPITUITARISM; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPINAL DISEASES; SPINAL FRACTURES; SPINE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 38649139894     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11102-007-0069-z     Document Type: Article

References (33)

1. Ohlsson C, Bengtsson BA, Isaksson OGP, Andreassen TT, Slootweg MC (1998) Growth hormone and bone. Endocr Rev 19:55-79
2. de Boer H, Block GJ, Van der Veen EA (1995) Clinical aspects of growth hormone deficiency in adults. Endocr Rev 16:63-86
3. Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A (2006) Growth hormone deficiency in adult. Pituitary 9:305-311
4. Wuster C (2000) Fracture rates in patients with growth hormone deficiency. Horm Res 54:31-35
5. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA (1997) Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 137:240-245
6. Wuster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P, KIMS Study Group and the KIMS International Board (2001) Pharmacia & upjohn international metabolic database. The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 16:398-405
7. Mazziotti G, Bianchi A, Bonadonna S, Nuzzo M, Cimino V, Fusco A, De Marinis L, Giustina A (2006) Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: Influence of GH replacement therapy. J Bone Miner Res 21:520-528
8. Doga M, Bonadonna S, Gola M, Mazziotti G, Nuzzo M, Giustina A (2005) GH deficiency in the adult and bone. J Endocrinol Invest 28(8 Suppl):18-23
9. Vandeweghe M, Taelman P, Kaufman JA (1993) Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol 39:409-415
10. Kann P, Piepkorn B, Schehler B, Andreas J, Lotz J, Prellwitz W, Beyer J (1998) Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clin Endocrinol 48:561-568
11. Davidson P, Milne R, Chase D, Cooper C (2004) Growth hormone replacement in adults and bone mineral density: A systematic review and meta-analysis. Clin Endocrinol 60:92-98
12. Nordin BE, Aaron J, Speed R, Crilly RG (1981) Bone formation and resorption as the determinants of trabecular bone volume in postmenopausal osteoporosis. Lancet 8:277-279
13. Hitz MF, Jensen JE, Eskildsen PC (2006) Bone mineral density in patients with growth hormone deficiency: Does a gender difference exist? Clin Endocrinol 65:783-791
14. Bengtsson BA, Abs R, Bennmarker H, Monson JP, Feldt-Rasmussen U, Hernberg-Stahl E, Westberg B, Wilton P, Wuster C, KIMS Study Group and the KIMS International Board (1999) The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. J Clin Endocrinol Metab 84:3929-3935
15. Drake WM, Rodriguez-Arnao J, Weaver JU, James IT, Coyte D, Spector TD, Besser GM, Monson JP (2001) The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: A 5-year study. Clin Endocrinol 54:525-532
16. Grigoryan M, Guermazi A, Roemer FW, Delmas PD, Genant HK (2003) Recognizing and reporting osteoporotic vertebral fractures. Eur Spine J 12:S104-112
17. Reeve J, Lunt M, Felsenberg D, Silman AJ, Scheidt-Nave C, Poor G, Gennari C, Weber K, Lorenc R, Masaryk P, Cannata JB, Dequeker J, Reid DM, Pols HA, Benevolenskaya LI, Stepan JJ, Miazgowski T, Bhalla A, Bruges Armas J, Eastell R, Lopes-Vaz A, Lyritis G, Jajic I, Woolf AD, Banzer D, Reisinger W, Todd CJ, Felsch B, Havelka S, Hoszowski K, Janott J, Johnell O, Raspe HH, Yershova OB, Kanis JA, Armbrecht G, Finn JD, Gowin W, O'Neill TW, European Prospective Osteoporosis Study Group (2003) Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: The European prospective osteoporosis study. J Bone Min Res 18:1664-1673
18. Siris ES, Genant HK, Laster AJ, Chen P, Misurski DA, Krege JH (2007) Enhanced prediction of fracture risk combining vertebral fracture status and BMD. Osteoporos Int 18:761-770
19. Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Shalet SM, Vance ML (2006) Evaluation and treatment of adult growth hormone deficiency: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 91:1621-1634
20. World Health Organization, Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. WHO Technical Report Series 1994, 843, Geneva, WHO
21. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. The european foundation for osteoporosis and bone disease. Osteoporos Int 7:390-406
22. Genant HK, Jergas M, Palermo L, Nevitt M, Valentin RS, Black D, Cummings SR (1996) Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in the osteoporosis. The study of osteoporotic fractures research group. J Bone Min Res 11:984-996
23. Lindsay R, Hart DM, Clark DM (1984) The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol 63:759-63
24. Wronski TJ, Cintron M, Doherty AL, Dann LM (1988) Estrogen treatment prevents osteopenia and depresses bone turnover in ovariectomized rats. Endocrinology 123:681-686
25. Kassem M, Okazaki R, Harris SA, Spelsberg TC, Conover CA, Riggs BL (1998) Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor. Calcif Tissue Int 62:60-66
26. Giustina A, Veldhuis JD (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
27. Mazziotti G, Angeli A, Bilezikian JP, Canalis E, Giustina A (2006) Glucocorticoid-induced osteoporosis: An update. Trends Endocrinol Metab 7:144-149
28. Khan AA, Hanley DA, Bilezikian JP, Binkley N, Brown JP, Hodsman AB, Josse RG, Kendler DL, Lewiecki EM, Miller PD, Olszynski WP, Petak SM, Syed ZA, Theriault D, Watts NB, Canadian Panel of the International Society for Clinical Densitometry (2006) Standards for performing DXA in individuals with secondary causes of osteoporosis. J Clin Densitom 9:47-57
29. Cefalu CA (2004) Is bone mineral density predictive of fracture risk reduction? Curr Med Res Opin 20:341-349
30. Olesik A, Ott SM, Vedi S, Bravenboer N, Compston J, Lips P (2000) Bone structure in patients with low bone mineral density with or without vertebral fractures. J Bone Min Res 15:1368-1375
31. Parfitt AM (1992) Implications of architecture for the pathogenesis and prevention of vertebral fracture. Bone 13:S41-44
32. Evans BA, Warner JT, Elford C, Evans SL, Laib A, Bains RK, Gregory JW, Wells T (2003) Morphological determinants of femoral strength in growth hormone-deficient transgenic growth-retarded (Tgr) rats. J Bone Miner Res 18:1308-1316
33. Lange M, Qvortrup K, Lander Svendsen O, Flyvbjerg A, Nowak J, Petersen MM, Olgaard K, Feldt-Rasmussen U (2004) Abnormal bone collagen morphology and decreased bone strength in growth hormone-deficient rats. Bone 35:178-185